PROGEN Cash Flow Statement - Prostatype Genomics AB - Alpha Spread
P

Prostatype Genomics AB
STO:PROGEN

Watchlist Manager
Prostatype Genomics AB
STO:PROGEN
Watchlist
Price: 0.019 SEK -7.32% Market Closed
Market Cap: 18.8m SEK
Have any thoughts about
Prostatype Genomics AB?
Write Note

Cash Flow Statement

Cash Flow Statement
Prostatype Genomics AB

Rotate your device to view
Cash Flow Statement
Currency: SEK
Mar-2022 Jun-2022 Sep-2022 Dec-2022 Mar-2023 Jun-2023 Dec-2023 Jun-2024
Operating Cash Flow
Net Income
(21)
(23)
(27)
(29)
(31)
(34)
(41)
(43)
Other Non-Cash Items
1
1
1
2
2
2
2
2
Change in Working Capital
(1)
1
(0)
(1)
(2)
(1)
10
5
Cash from Operating Activities
(22)
N/A
(21)
+6%
(25)
-23%
(28)
-10%
(31)
-12%
(36)
-15%
(29)
+18%
(33)
-14%
Investing Cash Flow
Capital Expenditures
(2)
(1)
(1)
0
(0)
(1)
(9)
(14)
Other Items
0
0
0
0
0
(0)
(0)
(0)
Cash from Investing Activities
(2)
N/A
(1)
+54%
(1)
+37%
0
N/A
(0)
N/A
(1)
-1 049%
(9)
-967%
(14)
-67%
Financing Cash Flow
Net Issuance of Common Stock
0
0
0
0
0
21
18
27
Net Issuance of Debt
(0)
(0)
(0)
(0)
(0)
(0)
11
10
Other
23
0
19
19
19
40
0
0
Cash from Financing Activities
23
N/A
23
0%
19
-17%
19
N/A
19
N/A
40
+110%
29
-27%
37
+29%
Change in Cash
Effect of Foreign Exchange Rates
0
0
0
0
0
0
(0)
0
Net Change in Cash
(1)
N/A
1
N/A
(7)
N/A
(9)
-24%
(12)
-39%
3
N/A
(9)
N/A
(10)
-16%
Free Cash Flow
Free Cash Flow
(24)
N/A
(22)
+11%
(26)
-20%
(28)
-7%
(31)
-12%
(36)
-17%
(38)
-4%
(47)
-26%

See Also

Discover More